QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Patent law tilts sharply toward holders; challengers face new barriers.

H.R. 3160 — PREVAIL Act · Filed by Nathaniel Moran (R-TX) · 2 cosponsors · Introduced May 1, 2025 · Referred to committee

72%
Transparency
Typical bill: 82%
18/100
Hidden-provision risk
Typical bill: 15/100
Patent System Restriction & Fee Autonomy

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

The PREVAIL Act amends U.S. patent law to make it harder for competitors to challenge patents through administrative proceedings (inter partes review and post-grant review). It restricts who can file these challenges, limits repetitive filings, requires higher evidentiary standards for challengers, and prevents patent owners from being sued in court or before the International Trade Commission on the same validity grounds once an administrative challenge is filed. It also stops the USPTO from diverting patent fees to other government programs and creates a dedicated patent fee fund.

Why we flagged it

The bill's core mechanism restricts administrative patent challenges (inter partes and post-grant review) through higher barriers, repetition limits, and estoppel rules, while simultaneously protecting USPTO fee autonomy from congressional diversion. The restrictions favor patent holders; the fee autonomy is structural reform.

What the text implies

  • The 'single forum' provision (Section 4 & 5) bars petitioners from raising validity challenges in federal court or before the ITC if an administrative review is instituted, effectively forcing all challenges into a single, patent-holder-friendly venue and preventing parallel litigation strategies.
  • The 'real party in interest' expansion (Sections 4 & 5) treats any entity making a financial contribution to a challenge as a party, potentially capturing nonprofits, universities, and public-interest organizations that fund patent challenges, subjecting them to estoppel and joinder rules.

The full analysis lists 5 implications of this text.

Who stands to gain

patent holders and patent-intensive companies; large technology and pharmaceutical firms with substantial patent portfolios; patent licensing entities and patent assertion entities (PAEs)

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record